Prescriber records on more than 3 million clinicians feed brand-specific models pharma marketers run across CTV, social and the open internet. Who audits them?

Prescriber records on more than 3 million clinicians feed brand-specific models pharma marketers run across CTV, social and the open internet. Who audits them?

Prescriber records on more than 3 million clinicians feed brand-specific models pharma marketers run across CTV, social and the open internet. Who audits them?

Prescriber records on more than 3 million clinicians feed brand-specific models pharma marketers run across CTV, social and the open internet. Who audits them?

Prescriber records on more than 3 million clinicians feed brand-specific models pharma marketers run across CTV, social and the open internet. Who audits them?

Prescriber records on more than 3 million clinicians feed brand-specific models pharma marketers run across CTV, social and the open internet. Who audits them?


 Every year, the U.S. healthcare system generates billions of data points, yet the most valuable information often hides in narrative notes that rarely make it into structured datasets. PurpleLab’s acquisition of Kaid Health aims to change that. By adding Kaid Health’s AI-driven chart analysis to its HealthNexus platform, PurpleLab can merge structured claims with the unstructured details of patient journeys. This opens the door to richer insights for coding, research, and care management. “Our vision is clear: we are now an AI-first healthcare intelligence company, and this acquisition accelerates that transformation,” said 

Data-driven, end-to-end platform enables marketing strategies that ensure compliance while maximizing impact across display, linear & Connected TV Innovative integration with leading healthcare analytics company PurpleLab provides powerful audience-building and reporting tools Nexxen, a global, flexible advertising platform with deep expertise in data and advanced TV, announced the launch of Nexxen Health, a new offering […]

PurpleLab is an efficient and readily deployable lab solution, providing a swift setup for cybersecurity professionals to test detection rules, simulate logs, and undertake various security tasks,...

Data: PurpleLab; Map: Axios Visuals The number of prescriptions for GLP-1 drugs jumped roughly 10% in 2024, according to insurance claims data provided to Axios by health analytics company PurpleLab. Why it matters: The data, which shows double-digit…

PurpleLab is a cybersecurity lab that integrates various tools and technologies to testing detection rules and simulating cyber threats.

The webinar, sponsored by PurpleLab and scheduled for May 22, will explore how healthcare sector companies can leverage real world data (RWD) with a focus on lung cancer.

The number of prescriptions for GLP-1 drugs jumped roughly 10% in 2024, according to insurance claims data analyzed by PurpleLab.

Data: PurpleLab; Map: Axios Visuals The number of prescriptions for GLP-1 drugs jumped roughly 10% in 2024, according to insurance claims data provided to Axios by health analytics company PurpleLab. Why it matters: The data, which shows double-digit growth in 23 states, offers a snapshot of the sustained growth in demand across the U.S. for the drugs hailed as game-changers in the fight against obesity. By the numbers: Rhode Island (67.8%), Massachusetts (48%) and New Jersey (35.8%) saw the largest year-over-year growth in prescriptions dispensed between 2023 and 2024. There were declines in six states including Arkansas, Louisiana, West Virginia, Idaho, South Dakota and Vermont. Between the lines: The most prescriptions went to adults ages 55 to 65 (29%), followed by seniors 65 and older (26%). The vast majority of prescriptions went to commercially insured patients while only 9% were written for Medicaid patients. 17% went to patients on Medicare. The data is based on roughly 7.5 billion claims from private insurers, as well as Medicare — which only covers GLP-1s to treat diabetes — and Medicaid. The data captures prescriptions for Novo Nordisk's diabetes drug Ozempic , which has been widely prescribed off-label for weight loss, and Wegovy, which was approved for weight loss in 2021. It also includes Eli Lilly's diabetes medication Mounjaro and its anti-obesity medication, Zepbound, which was approved by the Food and Drug Administration in November. The data lumps the prescriptions together, so it's not possible to tease out how often these drugs are being prescribed for obesity versus diabetes or heart disease.

A new eBook, sponsored by PurpleLab, examines how a significant number of patients with non-small cell lung cancer miss out on optimal care due to gaps in biomarker testing, socioeconomic barriers, incomplete patient journey data, and what can be done to change that.

A new eBook published by MedCity News for PurpleLab highlights how RWD and SDOH can lead to more inclusive clinical trials and drugs that improve the quality of life for larger, diverse patient populations not only for NSCLC, but other conditions as well.

The number of prescriptions for GLP-1 drugs jumped roughly 10% in 2024, according to insurance claims data analyzed by PurpleLab.

Trouvez votre centre de planning familial à Bruxelles et en Wallonie. Accueil gratuit et consultations sur rendez-vous. Confidentialité, non-jugement, accessibilité.


 Every year, the U.S. healthcare system generates billions of data points, yet the most valuable information often hides in narrative notes that rarely make it into structured datasets. PurpleLab’s acquisition of Kaid Health aims to change that. By adding Kaid Health’s AI-driven chart analysis to its HealthNexus platform, PurpleLab can merge structured claims with the unstructured details of patient journeys. This opens the door to richer insights for coding, research, and care management. “Our vision is clear: we are now an AI-first healthcare intelligence company, and this acquisition accelerates that transformation,” said 

PurpleLab is a cybersecurity lab that integrates various tools and technologies to testing detection rules and simulating cyber threats.